The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8586544 B1

PDF
Full Text
Expired
Date of Patent:
Nov. 19, 2013

Filed:

Apr. 03, 2009
Applicants:

Daewoong JO, Seoul, KR;

Jong Min Lee, Suwon-si, KR;

Kyoungho Park, Gwangju, KR;

Minh Tam Duong, Seoul, KR;

Inventors:

Daewoong Jo, Seoul, KR;

Jong Min Lee, Suwon-si, KR;

Kyoungho Park, Gwangju, KR;

Minh Tam Duong, Seoul, KR;

Assignees:

Procell Therapeutics Inc., Seoul, KR;

Other;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a cell-permeable endostatin recombinant protein in which a macromolecule transduction domain (MTD) is fused to an angiogenesis inhibitor (angiogenesis inhibitor) endostatin; a polynucleotide encoding the cell-permeable endostatin recombinant protein; an expression vector for the cell-permeable endostatin recombinant protein; and a pharmacological composition for an anti-cancer preparation with improved inhibitory activity against angiogenesis in cancer, which contains the cell-permeable endostatin recombinant protein as an active component. The cell-permeable endostatin recombinant protein according to the present invention can block the formation of microvessels and inhibit the migration, proliferation, penetration, tube formation and the like of vascular endothelial cells present in tumor tissue by introducing the angiogenesis inhibitor endostatin into the cell with high efficiency, and it exhibits outstanding anti-cancer activity and so can be used as an anti-cancer drug against various cancers.


Find Patent Forward Citations

Jo, Daewoong. (2013). Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component (U.S. Patent No. 8586544). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8586544

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…